Skip to main content
Journal of Patient-Reported Outcomes

Table 2 Medians (95% confidence intervals) of EQ-VAS, EQ-5D index, and derived disability weights by different clinical factors

From: Hepatic schistosomiasis, upper gastrointestinal bleeding, and health related quality of life measurements from the Albert Nile Basin

  n EQ-VAS EQ-5D index EQ-VAS derived disability weights EQ-5D index derived disability weights
Median 95% CI Median 95% CI Median 95% CI Median 95% CI
All participants 101 70 60, 70 0.59 0.59, 0.62 0.30 0.30, 0.40 0.34 0.31, 0.35
Age, years          
18–29 4 75 70, 90 0.67 0.59, 0.73 0.25 0.10, 0.30 0.26 0.21, 0.35
30–39 25 70 60, 80 0.62 0.52, 0.62 0.30 0.20, 0.40 0.31 0.31, 0.38
40–49 36 65 50, 70 0.62 0.59, 0.62 0.35 0.30, 0.50 0.31 0.31, 0.35
50–59 18 50 40, 80 0.59 0.09, 0.73 0.50 0.20, 0.60 0.38 0.31, 0.53
60–69 15 60 50, 70 0.52 0.19, 0.62 0.40 0.30, 0.50 0.40 0.31, 0.50
≥ 70 3 30 20, 60 − 0.13 − 0.18, − 0.13 0.70 0.40, 0.80 0.78 0.77, 0.78
Men 40 70 50, 80 0.62 0.59, 0.66 0.30 0.20, 0.50 0.31 0.30, 0.35
Women 61 60 50, 70 0.55 0.52, 0.62 0.40 0.30, 0.50 0.36 0.31, 0.40
Fisherman 14 70 50, 80 0.68 0.58, 0.79 0.30 0.20, 0.50 0.33 0.21, 0.42
Farmer 76 70 60, 70 0.65 0.62, 0.70 0.30 0.30, 0.40 0.35 0.31, 0.38
Jaundice          
No 90 70 60, 70 0.62 0.59, 0.62 0.30 0.30, 0.40 0.31 0.31, 0.35
Yes 11 60 40, 70 0.52 − 0.16, 0.59 0.40 0.30, 0.60 0.40 0.34, 0.68
Edema          
No 90 70 60, 70 0.62 0.59, 0.62 0.30 0.30, 0.40 0.31 0.31, 0.35
Yes 11 40 30, 50 0.15 − 0.18, 0.62 0.60 0.50, 0.70 0.48 0.31, 0.77
Splenomegaly          
No 8 65 20, 90 0.57 − 0.35, 0.80 0.35 0.10, 0.80 0.36 0.17, 0.99
Yes 89 70 60, 70 0.62 0.59, 0.62 0.30 0.30, 0.40 0.32 0.31, 0.35
Tense ascites (exam difficult) 4 30 10, 40 0.12 − 0.59, 0.15 0.70 0.60, 0.90 0.51 0.48, 1.15
Praziquantel          
No 11 80 70, 90 0.66 0.52, 0.80 0.2 0.10, 0.30 0.30 0.17, 0.34
Yes 90 60 50, 70 0.59 0.52, 0.62 0.4 0.30, 0.50 0.35 0.31, 0.40
Body mass index ≤ 18.5          
No 84 70 60, 70 0.62 0.59, 0.62 0.3 0.30, 0.40 0.31 0.31, 0.35
Yes 17 50 40, 70 0.52 1.66, 0.62 0.5 0.30, 0.60 0.41 0.31, 0.78
Liver fibrosis pattern score          
C 5 60 50, 90 0.59 − 0.13, 0.70 0.4 0.10, 0.50 0.35 0.21–0.78
D 34 70 60, 80 0.62 0.55, 0.66 0.3 0.20, 0.40 0.31 0.30, 0.35
E 21 70 50, 80 0.62 0.52, 0.62 0.3 0.20, 0.50 0.32 0.31, 0.40
F 3 50 50, 80 0.59 0.52, 0.62 0.5 0.20, 0.50 0.36 0.31, 0.40
X 38 60 50, 70 0.59 0.24, 0.62 0.35 0.31, 0.42 0.35 0.31, 0.42
Ascites by ultrasound          
No 87 70 60, 70 0.62 0.59, 0.62 0.3 0.30,0.40 0.31 0.31, 0.35
Yes 14 40 30, 50 0.15 − 1.26, 0.52 0.6 0.50, 0.70 0.48 0.40, 0.77
Varices          
No 18 70 50, 80 0.6 0.52, 0.67 0.3 0.20, 0.50 0.33 0.30, 0.40
Yes 83 70 50, 70 0.59 0.52, 0.63 0.3 0.30, 0.50 0.35 0.31, 0.36
Acute upper gastrointestinal bleeding          
No 79 70 70, 80 0.62 0.59, 0.62 0.3 0.20, 0.30 0.31 0.31, 0.35
Yes 22 40 30, 50 0.2 − 0.13, 0.59 0.6 0.50, 0.70 0.45 0.36, 0.68
Urine CCA          
No 93 70 60, 70 0.59 0.52, 0.62 0.3 0.30,0.40 0.35 0.31, 0.36
Yes 8 65 0, 80 0.6 − 0.13, 0.62 0.35 0.20, 1.0 0.33 0.31, 0.78
Anemia grade (gm/dl)          
< 6.5 20 50 40, 70 0.6 0.29, 0.64 0.5 0.30, 0.60 0.40 0.36, 0.71
6.5–7.9 12 50 31, 69 0.56 0.47, 0.55 0.5 0.31, 0.69 0.44 0.35, 0.53
8.0–9.4 15 60 50, 80 0.65 0.60, 0.70 0.4 0.20, 0.50 0.35 0.31, 0.40
9.5–10.9 16 65 55, 80 0.72 0.62, 0.79 0.35 0.20, 0.45 0.28 0.21, 0.38
≥ 11.0 38 75 70, 80 0.7 0.69, 0.70 0.25 0.20, 0.30 0.31 0.30, 0.31
Hepatitis B surface antigen positive          
No 94 60 50, 70 0.65 0.62, 0.70 0.4 0.30, 0.50 0.35 0.31, 0.38
Yes 7 80 70, 87 0.7 0.65, 0.79 0.2 0.13, 0.30 0.31 0.21, 0.35
  1. UGIB-upper gastrointestinal bleeding, 95CI – 95% confidence intervals
Back to article page